A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Eprosartan | Eprosartan is an angiotensin II receptor blocker (ARB) used primarily for the treatment of hypertension (high blood pressure). Eprosartan blocks the action of angiotensin II, a hormone that causes blood vessels to constrict, thereby increasing blood pressure. By blocking angiotensin II receptors, eprosartan allows blood vessels to relax and widen, which helps lower blood pressure. Eprosartan is indicated for the treatment of hypertension to lower blood pressure and reduces the risk of cardiovascular events such as heart attack and stroke. Uses: Prototype of the imidazoleacrylic acid angiotensin ii receptor antagonists. antihypertensive. Synonyms: 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-; (αE)-α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic acid; 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (E)-; (E)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid; Navixen; SKB 108566; SKF 108566; Teveten. Grade: 98%. CAS No. 133040-01-4. Molecular formula: C23H24N2O4S. Mole weight: 424.51. |  |
| Eprosartan | Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC 50 s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SKF-108566J free base. CAS No. 133040-01-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-117743. |  |
| Eprosartan acyl glucuronide | A derivative of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic Acid β-D-Glucuronide. Grade: > 95%. Molecular formula: C29H32N2O10S. Mole weight: 600.65. | |
| Eprosartan-d3 | Labeled Eprosartan, a prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Eprosartan is an antihypertensive. Group: Biochemicals. Alternative Names: (αE)-α-[[2-(Butyl-d3)-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (E)-2-(Butyl-d3)-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic Acid; Navixen-d3; SKB 108566-d3; SKF 108566-d3; Teveten-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| Eprosartan-[d3] | Eprosartan-[d3] is the labelled analogue of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: Eprosartan D3; (αE)-α-[[2-(Butyl-d3)-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (E)-2-(Butyl-d3)-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic Acid. Grade: 95% by HPLC; 95% atom D. CAS No. 1185243-70-2. Molecular formula: C23H21D3N2O4S. Mole weight: 427.53. | |
| Eprosartan ((E)-3-[2-Butyl-1-[(4-carboxyphenyl)-methyl]imidazol-5-l]-2-(2-thienylmethyl)-2-propenoic Acid) | Prototype of the imidazoleacrylic Acid angiotensin II receptor antagonists. Group: Biochemicals. Alternative Names: (E)-3-[2-Butyl-1-[(4-carboxyphenyl)-methyl]imidazol-5-l]-2-(2-thienylmethyl)-2-propenoic Acid. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Eprosartan ethyl methyl diester | Eprosartan ethyl methyl diester. Group: Biochemicals. Alternative Names: (a-E) -a-[[2-Butyl-1-[[4- (methoxycarbonyl) phenyl]methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic acid ethyl ester; Methyl 4-((5-((E)-2-(ethoxycarbonyl)-3-(thien-2-yl)prop-1-enyl)-2-butyl-1H-imidazol-1-yl)methyl)benzoate. Grades: Highly Purified. CAS No. 133486-13-2. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C26H30N2O4S. US Biological Life Sciences. | Worldwide |
| Eprosartan Impurity 1 | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (E)-methyl 4-((2-butyl-5-(3-ethoxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoate. Grade: > 95%. Molecular formula: C26H30N2O4S. Mole weight: 466.60. | |
| Eprosartan Impurity 2 | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: 2-((2-butyl-1-(4-carboxybenzyl)-1H-imidazol-5-yl)methylene)malonic acid. Grade: > 95%. Molecular formula: C19H20N2O6. Mole weight: 372.38. | |
| Eprosartan Impurity 3 | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (E)-4-((2-butyl-5-(2-carboxyvinyl)-1H-imidazol-1-yl)methyl)benzoic acid. Grade: > 95%. Molecular formula: C18H20N2O4. CH4O3S. Mole weight: 328.37 96.11. | |
| Eprosartan Impurity 4 | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: 4-((2-butyl-5-formyl-1H-imidazol-1-yl)methyl)benzoic acid. Grade: > 95%. CAS No. 152146-59-3. Molecular formula: C16H18N2O3. Mole weight: 286.33. | |
| Eprosartan Impurity 5 | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (E)-4-((2-butyl-5-(3-carboxy-1,4-di(thiophen-2-yl)but-2-en-2-yl)-1H-imidazol-1-yl)methyl)benzoic acid. Grade: > 95%. Molecular formula: C28H28N2O4S2. Mole weight: 520.69. | |
| eprosartan mesylate | eprosartan mesylate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Eprosartan Methanesulfonate. Product Category: Thiophenes. Appearance: White to Off-White Solid. CAS No. 144143-96-4. Molecular formula: C23H24N2O4S·CH4O3S. Mole weight: 520.62. Purity: 0.99. Product ID: ACM144143964. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Eprosartan mesylate | Eprosartan mesylate (SKF-108566J) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan mesylate binds angiotensin II receptor with IC 50 s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SKF-108566J. CAS No. 144143-96-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15834A. | |
| Eprosartan mesylate | Eprosartan mesylate. Group: Biochemicals. Grades: Purified. CAS No. 144143-96-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Eprosartan mesylate | Eprosartan mesylate. CAS No: 144143-96-4 |  Sarchem Laboratories New Jersey NJ |
| Eprosartan Mesylate | Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells. Synonyms: 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1); 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (E)-, monomethanesulfonate; 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, monomethanesulfonate; Eprosartan methanesulfonate; SKF 108566J; SKF-108566J; SKF108566J. Grade: >98%. CAS No. 144143-96-4. Molecular formula: C23H24N2O4S.CH4O3S. Mole weight: 520.62. | |
| Eprosartan RC A ( (E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid(Debenzyl Eprosartan) ) | Eprosartan RC A ( (E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid(Debenzyl Eprosartan) ) | Sarchem Laboratories New Jersey NJ |
| Eprosartan RC B (3-(Thiophen-2-yl)propanoic acid (Thiophenpropionic acid) | Eprosartan RC B (3-(Thiophen-2-yl)propanoic acid (Thiophenpropionic acid) | Sarchem Laboratories New Jersey NJ |
| Eprosartan RC C (2-[(Thiophene-2-yl)methyl] malonic acid (Bromomethylbenzoic acid)) | Eprosartan RC C (2-[(Thiophene-2-yl)methyl] malonic acid (Bromomethylbenzoic acid)) | Sarchem Laboratories New Jersey NJ |
| Eprosartan RC D (4-Bromomethylbenzoic acid (Bromomethylbenzoic acid)) | Eprosartan RC D (4-Bromomethylbenzoic acid (Bromomethylbenzoic acid)). CAS No: 6232-88-8 | Sarchem Laboratories New Jersey NJ |
| Eprosartan RC F ((Z) -4-({2-Butyl-5-[2-carboxy-3-(thiophen-2-yl) prop-1-enyl]-1H-imidazol-1-yl}methyl)benzoic acid(Z-Eprosartan)) | Eprosartan RC F ((Z) -4-({2-Butyl-5-[2-carboxy-3-(thiophen-2-yl) prop-1-enyl]-1H-imidazol-1-yl}methyl)benzoic acid(Z-Eprosartan)) | Sarchem Laboratories New Jersey NJ |
| Eprosartan related compound A | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: N-Descarboxyphenyl eprospartan; ((E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)Acrylic Acid. Grade: > 95%. CAS No. 1169702-90-2. Molecular formula: C15H18N2O2S. Mole weight: 290.39. | |
| Eprosartan Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Eprosartan Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Eprosartan related compound C | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (2-Thenyl)malonic acid, 2-(2-Thienylmethyl)propanedioic acid, 2-(Thiophen-2-ylmethyl)malonic acid. Grade: > 95%. CAS No. 4475-24-5. Molecular formula: C8H8O4S. Mole weight: 200.21. | |
| Eprosartan Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Eprosartan Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Eprosartan Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Eprosartan related compound F | An impurity of Eprosartan. Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. Synonyms: (Z)-Eprosartan; (αZ)-α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid. Grade: > 95%. CAS No. 148674-39-9. Molecular formula: C23H24N2O4S. Mole weight: 424.52. | |
| Eprotirome | Eprotirome is a synthetic thyroid hormone mimetic as a thyroid hormone receptor beta agonists, lowers total and low-density lipoprotein cholesterol up to 40% without affecting high-density lipoprotein cholesterol levels and without deleterious side effects to the cardiovascular system. Uses: Thyroid hormone receptor beta agonists. Synonyms: KB-2115; KB 2115; KB2115; Eprotirome.3-[[3,5-dibromo-4-[4-hydroxy-3-(1-methylethyl)phenoxy]phenyl]amino-3-oxo-propanoic acid. Grade: ≥98%. CAS No. 355129-15-6. Molecular formula: C18H17Br2NO5. Mole weight: 487.14. | |
| Eprotirome | Eprotirome (KB2115) is a liver-selective thyroid hormone receptor (TR) agonist. KB2115 has modestly higher affinity for TRβ than for TR&alpha. Eprotirome reduces low-density lipoprotein (LDL) cholesterol concentrations. Eprotirome can be used for dyslipidemias and obesity research [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: KB2115. CAS No. 355129-15-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10473. | |
| epsilon-caprolactone | epsilon-caprolactone. CAS No. 502-44-3. Cenik is your partner of choice for specialised chemicals. We don't just provide products - we supply solutions to your technical and regulatory specifications. |  |
| epsilon-Caprolactone | Liquid;COLOURLESS HYGROSCOPIC LIQUID WITH CHARACTERISTIC ODOUR. Group: Polymers. CAS No. 502-44-3. Product ID: oxepan-2-one. Molecular formula: 114.14g/mol. Mole weight: C6H10O2;C6H10O2. C1CCC(=O)OCC1. InChI=1S / C6H10O2 / c7-6-4-2-1-3-5-8-6 / h1-5H2. PAPBSGBWRJIAAV-UHFFFAOYSA-N. |  |
| epsilon-Cyclodextrin | epsilon-Cyclodextrin is a modified cyclodextrin widely used in the biomedical industry. It facilitates the delivery of drugs by forming inclusion complexes, enhancing their solubility and stability. With its unique structure, epsilon-Cyclodextrin is applied in the research of various diseases, including cancer, diabetes and Alzheimer's. Synonyms: Cyclomaltodecaose; CD10. CAS No. 156510-98-4. Molecular formula: C60H100O50. Mole weight: 1621.41. | |
| epsilon-Dinitrophenyllysine | epsilon-Dinitrophenyllysine. Synonyms: Dinitrophenyl-lysine; epsilon-Dinitrophenylated-lysine; DNP-L-Lys; N(6)-(2,4-dinitrophenyl)-L-lysine; epsilon-N-(2,4-Dinitrophenyl)-L-lysine; H-Lys(Dnp)-OH. CAS No. 1094-76-4. Molecular formula: C12H16N4O6. Mole weight: 312.28. | |
| Epsom Salt | Epsom Salt (Magnesium Sulfate, Heptahydrate). Products can be packaged according to specific requirements and as per international standards for export shipments. Categories: magnesium sulfate heptahydrate; 10034-99-8; epsom salt. |  Worldwide |
| Ept | Ept. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 5-ETHYL-2,4-DIHYDRO-4-(2-PHENOXYETHYL)-3H-1,2,4-TRIAZOLE-3-ONE;5-ETHYL-4-(2-PHENOXYETHYL)-1,2,4-TRIAZOL-3-ONE;5-ETHYL-4-(2-PHENOXYETHYL)-2H-1,2,4-TRIAZOL 3(4H)-ONE;5-ETHYL-4-(2-PHENOXYETHYL)-2H-1,2,4-TRIAZOL-3-ONE;5-Ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazole-3-(4H)-one;EPT;5-Ethyl-2,4-Dihydro-4-(2-Phenoxyethyl)-3h-1,2,4-Triazol-3-One;5-Ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazole-3-one (EPT). CAS No. 95885-13-5. Molecular formula: C12H15N3O2. Mole weight: 233.27. Purity: 0.96. IUPACName: 3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5-one. Canonical SMILES: CCC1=NNC(=O)N1CCOC2=CC=CC=C2. Density: 1.21g/cm³. Product ID: ACM95885135. Alfa Chemistry ISO 9001:2015 Certified. | |
| Eptapirone | Eptapirone, a triazine derivative, has been found to be a 5-HT1A receptor agonist and was once studied as an antidepressant agent. pKi: 8.33. Synonyms: F11440; F-11440; F 11440; Eptapirone; L0068; L-0068; L 0068; Eptapirone; Eptapirone [INN]; F 11440; 4-methyl-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2,4-triazine-3,5-dione. Grade: 98%. CAS No. 179756-85-5. Molecular formula: C16H23N7O2.C4H4O4. Mole weight: 461.47. | |
| Eptaplatin | A coordination compound for treatment of cervix cancer. Group: Biochemicals. Alternative Names: (SP-4-2)-[(4R, 5R)-2-(1-Methylethyl-1, 3-dioxolane4, 5-dimethanamine-kN4, kN5][propanedioato(2-)-kO1, kO3]platinum; Heptaplatin; cis-[ (4R, 5R)-4, 5-bis (aminomethyl)-2-isopropyl-1, 3-dioxolane] (malonate)platinum (II); SKI 2053R. Grades: Highly Purified. CAS No. 146665-77-2. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| EPTC-[d14] | EPTC-[d14] is the labelled analogue of EPTC, which is a pesticide. Synonyms: EPTC-d14 (di-n-propyl-d14); S-Ethyl-N,N-dipropylthiocarbamate-d14; S-Ethyl dipropylthiocarbamate-d14; EPTAM-d14; Torbin-d14; Eptam 6E-d14; Alirox-d14; Niptan-d14; Witox-d14. Grade: 99% atom D. CAS No. 1219794-88-3. Molecular formula: C9H5D14NOS. Mole weight: 203.40. | |
| Eptifibatide | An arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events. Uses: Platelet aggregation inhibitors. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide; Eftifibatide; Integrelin; Integrilin; Intrifiban; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys bridge); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide; deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7). Grade: 98%. CAS No. 188627-80-7. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| Eptifibatide | Eptifibatide is a Platelet Aggregation Inhibitor. The physiologic effect of eptifibatide is by means of Decreased Platelet Aggregation. Alternative Names: Integrelin. Integrilin. Intrifiban. CAS No. 188627-80-7. Product ID: API188627807. Molecular formula: C35H49N11O9S2. Mole weight: 832. EINECS: 641-366-7. SMILES: C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N. Category: Peptide APIs. |  |
| Eptifibatide | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor , with anti-platelet activity [1]. Uses: Scientific research. Group: Peptides. CAS No. 188627-80-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0686. | |
| Eptifibatide | Eptifibatide. Categories: eptifibatide; 188627-80-7. |  CA, FL & NJ |
| Eptifibatide | Eptifibatide. Group: Biochemicals. Grades: Purified. CAS No. 188627-80-7. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Eptifibatide acetate | Eptifibatide acetate, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. It reversibly binds to platelets to reduce the risk of cardiac ischemic events. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide, acetate (1:x); deamino-Cys(1)-hArg-Gly-Asp-Trp-Pro-Cys(1)-NH2.xCH3CO2H; Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide acetate salt; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 (Mpr&Cys bridge) acetate. Grade: ≥95%. CAS No. 881997-86-0. Molecular formula: C35H49N11O9S2.xC2H4O2. Mole weight: 831.97 (free base). | |
| Eptifibatide Acetate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-?-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1?6)-disulfide, acetate (9CI), Eptifibatide acetate,L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-?-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1?6)-disulfide, acetate (1:?). | |
| Eptifibatide Dimer (Antiparallel) | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys,Cys&Mpr bridge); Mpr-Har-GDWPC-NH2(Mpr&Cys,Cys&Mpr bridge); Eptifibatide (Dimer, unparallel); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2.deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7', Cys7-Cys1'); L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→6'),(6→1')-bis(disulfide); Eptifibatide Dimer; N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6'),(6-1')-bis(disulfide); Eptifibatide Impurity 3. Grade: ≥95%. CAS No. 1505450-99-6. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide Dimer (parallel) | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Mpr,Cys&Cys bridge); Mpr-Har-GDWPC-NH2(Mpr&Mpr,Cys&Cys bridge); Eptifibatide Dimer(parallel); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2.deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys1', Cys7-Cys7'); L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide); Eptifibatide Dimer; N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-Lprolyl-L-cysteinamide, cyclic(1-1'),(6-6')-bis(disulfide). Grade: ≥95%. CAS No. 1505451-00-2. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide Impurity 1 | Eptifibatide Impurity 1 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C35H48N10O10S2. Mole weight: 832.95. | |
| Eptifibatide Impurity 2 | Eptifibatide Impurity 2 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C35H51N11O10S2. Mole weight: 849.98. | |
| Eptifibatide Impurity 3 | Eptifibatide Impurity 3 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide monoacetate | Eptifibatide monoacetate, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. It reversibly binds to platelets to reduce the risk of cardiac ischemic events. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide, acetate (1:1); deamino-Cys(1)-hArg-Gly-Asp-Trp-Pro-Cys(1)-NH2.CH3CO2H; Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide acetic acid; Eptifibatide acetate; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 (Mpr&Cys bridge) acetate. Grade: ≥95%. CAS No. 1248559-53-6. Molecular formula: C35H49N11O9S2.C2H4O2. Mole weight: 892.02. | |
| Eptifibatide Trisulfide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys Trisulfidebridge); Mpr-Har-GDWPC-NH2(Mpr&Cys Trisulfidebridge); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Trisulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-trisulfide; Trisulphide Eptifibatide. Grade: ≥95%. Molecular formula: C35H49N11O9S3. Mole weight: 864.03. | |
| Eptinezumab | Eptinezumab is a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP). Eptinezumab has been used for the preventive treatment of migraine in adults. Synonyms: Vyepti. CAS No. 1644539-04-7. | |
| Eptinezumab | Eptinezumab is a humanized monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its interaction with the receptor. Eptinezumab is used for the prevention of migraine in adults [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1644539-04-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99017. | |
| eptotermin alfa | eptotermin alfa. Uses: Designed for use in research and industrial production. Additional or Alternative Names: eptotermin alfa. Product Category: Heterocyclic Organic Compound. CAS No. 129805-33-0. Molecular formula: Na+. Purity: 0.96. IUPACName: sodium(1+). Canonical SMILES: [Na+]. Product ID: ACM129805330. Alfa Chemistry ISO 9001:2015 Certified. | |
| e-Pyrrole-lysine 99+% (HPLC) | e-Pyrrole-lysine 99+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| EPZ004777 | EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 0.4 nM in a cell-free assay and demonstrates >1,200-fold selectivity for DOT1L over all other tested PMTs. EPZ004777 induces apoptosis. Group: Inhibitors. CAS No. 1338466-77-5. Pack Sizes: 5mg. Product ID: S7353. Formula: C28H41N7O4. Smiles: CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C(N=CN=C43)N)O)O. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| EPZ004777 | EPZ004777 is a potent, selective inhibitor of DOT1L. Treatment of mixed lineage leukemia (MLL) cells with EPZ004777 selectively inhibits H3K79 methylation and blocks expression of leukemogenic genes. Exposure of leukemic cells to EPZ004777 results in selective killing of those cells bearing the MLL gene translocation, with little effect on non-MLL-translocated cells. Finally, in vivo administration of EPZ004777 leads to extension of survival in a mouse MLL xenograft model. These results provide compelling support for DOT1L inhibition as a basis for targeted therapeutics against MLL. Uses: Reprogramming. Synonyms: EPZ004777; EPZ 004777; EPZ-004777. Grade: 0.98. CAS No. 1338466-77-5. Molecular formula: C28H41N7O4. Mole weight: 539.681. | |
| EPZ004777 | EPZ004777 is a potent, selective DOT1L inhibitor with an IC50 of 0.4 nM. Uses: Scientific research. Group: Signaling pathways. CAS No. 1338466-77-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-15227. | |
| EPZ004777 hydrochloride | EPZ004777 selectively inhibits cellular H3K79 methylation and inhibits expression of key MLL fusion target genes. Following DOT1L inhibition, EPZ004777 selectively inhibits proliferation of MLL-Rearranged cell lines and MLL-AF9-transformed murine hematopoietic cells. In addition, EPZ004777 also induces differentiation and apoptosis in MLL-rearranged cells. EPZ004777 selectively inhibits proliferation of MLL-AF10 and CALM-AF10-transformed murine bone marrow cells. DOT1L inhibition by EPZ004777 results in significantly decreased proliferation, decreased expression of MLL-AF6 target genes, and cell cycle arrest of MLL-AF6-transformed cells. Synonyms: EPZ 004777 hydrochloride; EPZ-004777 hydrochloride; EPZ004777 hydrochloride. Grade: >98%. CAS No. 1380316-03-9. Molecular formula: C28H42ClN7O4. Mole weight: 576.13. | |
| EPZ005687 | EPZ005687 is a selective EZH2 enzyme inhibitor with Ki of 24 nM. It is 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases. EPZ005687 can block trimethylation of the PRC2 target histone 3 lysine 27 with IC50 value of 80 nM, decreasing the proliferation of lymphoma cells carrying mutant, but not wild-type, EZH2. No development of preclinical research for the treatment of Cancer, Lymphoma and Solid tumours was reported. Uses: Cancer; lymphoma; solid tumours. Synonyms: EPZ005687; EPZ 005687; EPZ-005687; 1-Cyclopentyl-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-6-[4-(4-morpholinylmethyl)phenyl]-1H-indazole-4-carboxamide; 1-Cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide. Grade: 98%. CAS No. 1396772-26-1. Molecular formula: C32H37N5O3. Mole weight: 539.67. | |
| EPZ005687 | EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases. Uses: Scientific research. Group: Signaling pathways. CAS No. 1396772-26-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15555. | |
| EPZ011989 | EPZ011989 is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ011989 has inhibitory inhibition for EZH2 with a Ki value of <3 nM. EPZ011989 shows robust methyl mark inhibition and anti-tumor activity. EPZ011989 can be used for the research of various cancers[1]. EPZ011989 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 1598383-40-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-16986. | |
| EPZ011989 | EPZ011989 is a potent, orally-available EZH2 inhibitor with robust in vivo activity. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. EPZ011989 represents a powerful tool for the expanded exploration of EZH2 activity in biology. Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications. The ability of the scientific community to explore fully the spectrum of EZH2-associated pathobiology has been hampered by the lack of in vivo-active tool compounds for this enzyme. Uses: Designed for use in research and industrial production. Additional or Alternative Names: EPZ011989; EPZ-011989; EPZ 011989. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 1598383-40-4. Molecular formula: C35H51N5O4. Mole weight: 605.82. Purity: >98%. IUPACName: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl((1r,4r)-4-((2-methoxyethyl)(methyl)amino)cyclohexyl)amino)-2-methyl-5-(3-morpholinoprop-1-yn-1-yl)benzamide. Canonical SMILES: O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(C#CCN3CCOCC3)=CC(N(CC)[C@H]4CC[C@H](N(CCOC)C)CC4)=C2C. Product ID: ACM1598383404. Alfa Chemistry ISO 9001:2015 Certified. | |
| EPZ011989 | EPZ011989 is a potent, orally-available EZH2 inhibitor with robust in vivo activity. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. Synonyms: EPZ011989; EPZ-011989; EPZ 011989. Grade: 98%. CAS No. 1598383-40-4. Molecular formula: C35H51N5O4. Mole weight: 605.82. | |
| EPZ011989 trifluoroacetate | EPZ011989 trifluoroacetate is the trifluoroacetate salt form of EPZ011989. EPZ011989 is a potent and orally bioavailable inhibitor that specifically targets the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2), with significant tumor growth in. Synonyms: EPZ011989 TFA salt; EPZ011989 TFA; EPZ 011989 TFA; EPZ-011989 TFA; N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl-[4-[2-methoxyethyl(methyl)amino]cyclohexyl]amino]-2-methyl-5-(3-morpholin-4-ylprop-1-ynyl)benzamide; 2,2,2-trifluoroacetic acidEPZ011989 (trifluoroacetate). CAS No. 1598383-41-5. Molecular formula: C37H52F3N5O6. Mole weight: 719.83. | |
| EPZ015666 | EPZ015666 shows potent cellular activity that blocks symmetric dimethylation of SmD3 and inhibit proliferation of MCL cell lines (Z-138, Granta-519, Maver-1, Mino, and Jeko-1) with IC50 of 96-904 nM. Synonyms: EPZ015666; EPZ-015666; EPZ 015666; GSK3235025; GSK-3235025; GSK 3235025. Grade: >98%. CAS No. 1616391-65-1. Molecular formula: C20H25N5O3. Mole weight: 383.44. | |
Our database is helping our users find suppliers everyday.
